Pan Drugs Ltd
- Market Cap ₹ Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield %
- ROCE %
- ROE %
- Face Value ₹ 10.0
Pros
Cons
- Company has low interest coverage ratio.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| TTM | |
|---|---|
| 25.10 | |
| 25.00 | |
| Operating Profit | 0.10 |
| OPM % | 0.40% |
| 0.49 | |
| Interest | 0.03 |
| Depreciation | 1.28 |
| Profit before tax | -0.72 |
| Tax % | |
| -0.72 | |
| EPS in Rs | -2.28 |
| Dividend Payout % |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -26% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -1540% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Figures in Rs. Crores
| Equity Capital |
| Reserves |
| Total Liabilities |
| CWIP |
| Investments |
| Total Assets |
Cash Flows
Figures in Rs. Crores
| Net Cash Flow |
| Free Cash Flow |
| CFO/OP |
Ratios
Figures in Rs. Crores
| Debtor Days |
| Inventory Days |
| Days Payable |
| Cash Conversion Cycle |
| Working Capital Days |
| ROCE % |
Documents
Announcements
- Shareholding for the Period Ended December 31, 2017 8 Jan 2018
- Shareholding for the Period Ended September 30, 2017 16 Oct 2017
- Shareholding for the Period Ended June 30, 2017 16 Oct 2017
- Statement Of Investor Complaints For The Quater Ended June,2017 14 Oct 2017
- PCS Certificate For Transfer/Transmission For The Quater Ended September,2017 14 Oct 2017
Annual reports
No data available.